AzTrials
AzTrials

Healthy AgingMATILDANCT05974605

Mindfulness and Attention Training Intervention to Lower Distractibility in Aging

A study testing MM+HighC in people with Healthy Aging, run by The University of Texas at Dallas at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this interventional study is to test the efficacy of combined mindfulness meditation training and cognitive training on brain function and cognition in healthy older adults. Read more about this study

Who is it for?
Ages 65 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Aging
What is being tested?
MM+HighC
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
17 Mar 2022to 27 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • right-handed
  • aged 65 to 85 years old
  • at least high school education
  • learned English before age 5.
  • screening cognitive assessment (MoCA) score above the threshold
  • physical and sensory capacity sufficient to undertake an fMRI study:
Show all 14Show fewer
  • the ability to stay still for the duration of the scan
  • sufficient finger dexterity to press buttons on the provided button boxes during the scan
  • vision acuity of at least 20/30 after correction
  • no color blindness
  • no claustrophobia
  • no metal implants above the waist
  • if female, cannot be pregnant or likely to be pregnant.
  • cannot have participated in similar training in the past two years.

Who cannot join

  • left-handed or ambidextrous
  • weigh over 300 lb
  • did not attain at least high school education
  • have not learned English before the age of 5
  • screening cognitive assessment (MoCA) score below the threshold
  • color blind
Show all 19Show fewer
  • have vision acuity worse than 20/30 after correction
  • experience of excessive hand tremor or other motor impairment related to hand movement
  • history of cardiovascular disease other than treated hypertension
  • diabetes
  • psychiatric disorders
  • illness or trauma affecting the central nervous system, including stroke and head trauma resulting in loss of consciousness over 5 seconds
  • substance/alcohol abuse
  • use of medication with anti-depressant, anti-psychotic effects (use of hypnotic medication is allowed only occasionally at bedtime).
  • certain medical devices or implants
  • non-medical sources of metal, e.g., shrapnel, prior hobby/work with metal
  • MRI image revealing evidence of pathology
  • female participants that are pregnant or likely to become pregnant
  • participated in similar training in the past two years

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Center for Vital Longevity

    Dallas, Texas, 75235

Other trials in United States

About this study

The goal of this interventional study is to test the efficacy of combined mindfulness meditation training and cognitive training on brain function and cognition in healthy older adults. Participants will undergo cognitive and neuroimaging (MRI and fNIRS) assessments before and after an 8-week (~20 hours) training intervention. The intervention will consist of at-home mindfulness meditation followed by playing a cognitive game on a provided tablet. The findings will be compared to an existing data from older adults who trained on the cognitive game only (NCT03988829; Arms 1 and 2).

Read the detailed description

Nearly 14 million people are projected to develop Alzheimer's disease (AD) by 2050 in the USA alone, with those affected by mild cognitive impairment (MCI) being especially at risk. Therefore, interventions aimed at prevention of dementia and promotion of brain and cognitive health in older adults need to be developed. One of the most successful types of non-pharmacological intervention is cognitive training, where participants engage in mental exercises targeting one or multiple cognitive domains. A recent meta-analysis has found that both healthy older adults and older adults affected by MCI, benefit equally in cognitive health from such training. Importantly, both populations showed improvements in cognitive abilities that were beyond the trained skills, such as everyday cognition, suggesting that cognitive training has a broad impact on independence in daily activities and quality of life. The training of attentional control has proven to be the most effective type of single-component training. Attentional control is the ability to focus attention to a task while inhibiting distractors; this "core" ability is fundamental for many everyday tasks. In addition to directly training attentional control, another promising approach to reducing distractibility is mindfulness meditation. As for the neural effects of attentional control training and meditation training, alterations in resting state brain function are reported, esp. in Default Mode Network (DMN) regions that are related to memory and attentional control. DMN is found to be engaged in older adults, but is disengaged in younger adults; this overactivation is detrimental to cognitive performance. However, the combined benefits of cognitive control training and mindfulness meditation on cognition and DMN are understudied in older adults.

In this project, there is a single training arm that will train healthy older adults on a combination training composed of high attentional control and mindfulness meditation using simulation based games. Neural and cognitive changes in near and far transfer tasks will be examined immediately after the intervention. These changes will be compared with that of a previously collected group of older adults who received only cognitive control training (NCT03988829; Arms 1 and 2). Changes in overall cognition (primary cognitive outcome) and changes in DMN connectivity during task (primary neuroimaging outcome) and rest (secondary neuroimaging outcome) in this combination training group will be compared to the respective changes in Arm 1 (low attentional control training) and Arm 2 (High Attentional Control training) of the existing dataset. The protocol of participant recruitment, pre- and post- training assessments (MRI and behavioral), and training platform remain same between this study and the existing database. In this current study, participants also undergo a functional near infra-red spectroscopy (fNIRS) session, after completion of behavioral and MRI session, at pre-training and post-training. This clinical trial will result in the development of more efficient behavioral intervention tools in older adults, based on neuroimaging evidence, that can be readily used from the comfort of home.

Conditions
Healthy Aging
Being tested
MM+HighC
Keywords
cognitive training, mindfulness meditation training, functional magnetic resonance imaging, improving cognition, improving brain function, simulation games

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MM+HighCBehavioural

    Also called Combined Mindfulness Meditation and Unpredictable Bird Watch, MM+CT

    In this intervention, participants will be trained on a available mindfulness meditation app, followed by a working memory updating game, developed by Dr. Chandramallika Basak. This game requires high degree of attentional control (Unpredictable Bird Watch), also known as High-C. The app and the game are delivered through an Android tablet for this home-based training.

Study groups in NCT05974605
Study groupRoleWhat they receive
Combined mindfulness meditation and cognitive trainingExperimentalParticipants train at home for 20 hours over 8 weeks, splitting the time between mindfulness meditation and cognitive training. Participants train for 30 minutes per day, for 5 days a weeks on a provided tablet computer. The participants are to keep a paper log of dates and durations. The mindfulness meditation portion of the training is a commercially available mobile app. Participants listen to guided meditations and follow the instructions. The program includes common mindfulness meditation exercises such as body scan or breath awareness. The cognitive training portion of the intervention uses a highly demanding attentional control training program BirdWatch game (BWGU). BWGU is a "gamified" n-back paradigm where participants randomly switch the focus of attention to update or maintain an adaptively growing set of bird stimuli in their working memory and are sometimes required to inhibit their response.
Receives: Behavioral: MM+HighC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in composite score of overall cognition

    Change in composite score of overall cognition from baseline to post-training (after 8 weeks). Overall composite score calculated from standardized scores of tasks of executive control (EC), processing speed (PS), working memory capacity (WMC), reasoning (R), episodic memory (EM), everyday memory. Higher scores represent better outcomes.

    The composite score for overall cognition will include correct responses (or their response times - RT) from:

    7 EC tasks: Task Switching (RT; fMRI task behavioral data) Dimensional Change Flanker (RT) Stroop (RT) Visual N-back Random N-back (fMRI task behavioral data) List Sorting Working Memory

    4 EM tasks: Picture Sequence Memory Rey Auditory Verbal Learning Test Story Recall Mnemonic Similarity Task (fMRI task behavioral data)

    2 R tasks: Matrix Reasoning Visual Puzzle

    1. WMC: Complex span
    2. PS tasks:

    Digit Symbol Substitution Task 0-back RT

    1 everyday cognition task: Rivermead Behavioural Memory Test

    Measured: 9-10 weeks (includes baseline assessment, training, and post-training assessment)

  2. Change in task-related functional connectivity of the DMN

    Change in task-related functional connectivity of the default mode network from baseline to post-training (i.e., after 8 weeks of training) in the random n-back fMRI task and at rest (resting-state scan is considered as the baseline condition).

    Measured: 9-10 weeks (includes baseline assessment, training, and post-training assessment)

Secondary outcomes (3)
  1. Change in task-related functional connectivity of the cognitive networks

    Change in task-related functional connectivity of the cognitive networks from baseline to post-training (i.e., after 8 weeks of training) in the random n-back fMRI task and at rest (resting-state scan is considered as the baseline condition).

    Measured: 9-10 weeks (includes baseline assessment, training, and post-training assessment)

  2. Change in the Composite Score of Psychosocial Functioning

    Change in composite score of Psychosocial Functioning from baseline to post-training (i.e., after 8 weeks). Overall composite score will be calculated from standardized scores of 3 questionnaires. Higher scores represent better outcomes.

    1. MIDUS 2 (Midlife in the United States 2)
    2. GDS (Geriatric Depression Scale)
    3. New General Self-Efficacy Scale

    Measured: 9-10 weeks (includes baseline assessment, training, and post-training assessment)

  3. Change in white matter structural connectivity

    Change in white matter structural connectivity (number of tracts that pass two ROIs and the fractional anisotropy sampled by the tracks) from baseline to post-training (i.e., after 8 weeks of training).

    Measured: 9-10 weeks (includes baseline assessment, training, and post-training assessment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2023
  2. Study start17 Mar 2022
  3. Primary completion1 Nov 2023
  4. Study completion27 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
The trail will collect data from a single group. The results will be compared to a previously collected data from two arms of an RCT.
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05974605
Sponsor's protocol ID
IRB-22-189
Acronym
MATILDA
Status last verified
Nov 2024
First submitted
25 Jul 2023
Last updated
3 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Geda YE. Mild cognitive impairment in older adults. Curr Psychiatry Rep. 2012 Aug;14(4):320-7. doi: 10.1007/s11920-012-0291-x.

    PubMed 22773365
  • Basak C, Qin S, O'Connell MA. Differential effects of cognitive training modules in healthy aging and mild cognitive impairment: A comprehensive meta-analysis of randomized controlled trials. Psychol Aging. 2020 Mar;35(2):220-249. doi: 10.1037/pag0000442. Epub 2020 Feb 3.

    PubMed 32011155

Questions about this trial

What is this clinical trial studying?

A study testing MM+HighC in people with Healthy Aging, run by The University of Texas at Dallas at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in composite score of overall cognition (time frame: 9-10 weeks (includes baseline assessment, training, and post-training assessment)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05974605, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in